How will the installation of a new tissue production line affect Apizaco?
Apizaco will host a new high-speed tissue production line starting in 2027. A complete turnkey tissue production plant is being installed at the Blue Tissue paper mill in Apizaco, Mexico. The project involves Toscotec supplying an AHEAD 2.2 tissue machine, which has a production capacity of up to 30,000 tons per year. The new line is part of GrandBay Group’s expansion strategy and is scheduled to begin operation in the first semester of 2027.
- Effect
- Strong positive
- How direct
- 2 steps, all reported
- When
- Over the long term
- The story
- Gone quiet
How it reaches Apizaco
-
Toscotec secured a contract to supply specialized machinery for a new PM2 tissue production line for GrandBay Group. The project involves installing an AHEAD 2.2 tissue machine at the Blue Tissue paper mill in Apizaco, Mexico, with a planned start-up in the first semester of 2027. This turnkey project is the third major installation for Toscotec in five years.
The full event1independent outlet -
Toscotec secured a turnkey project for GrandBay Group, which includes supplying an AHEAD 2.2 tissue machine designed for high-speed production of premium toilet tissue and kitchen towel paper.
1 report connects these two. Brind only summarizes; follow a link to read the reporting itself.
- pulpapernews.com Oct 6
-
Italian company
Everything about Toscotec -
The AHEAD 2.2 machine, which has a sheet width of 2,750 mm and a capacity of up to 30,000 tons/Year, will be installed at the Blue Tissue paper mill located in Apizaco, Mexico, with a start-up planned for the first semester of 2027.
1 report connects these two. Brind only summarizes; follow a link to read the reporting itself.
- pulpapernews.com Oct 6
-
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- Toscotec will supply an AHEAD 2.2 tissue machine for the Blue Tissue paper mill in Apizaco, Mexico.pulpapernews.com
- The new line has a production capacity of up to 30,000 tons/Year.pulpapernews.com
- The start-up of the new line is planned for the first semester of 2027.pulpapernews.com
- This project is part of GrandBay Group’s expansion strategy in Latin America.pulpapernews.com
Why it matters
The installation of a major, high-capacity tissue production plant represents a significant industrial development for Apizaco. This project is a cornerstone of GrandBay Group’s strategy to consolidate its position as a leading group in the tissue paper market across Latin America.
This investment follows previous successful installations by Toscotec for GrandBay Group subsidiaries in other Latin American countries, including Papelera Internacional in Guatemala and Papeles Nacionales in Colombia, highlighting the region's growing focus on advanced tissue manufacturing.
What we don't know yet
- What specific economic or employment benefits will the new plant bring to the local community in Apizaco?
- How will the new line's focus on optimizing water, fibers, and energy impact local environmental regulations?
What would change this answer
— Other considerations
Beyond this explainer
Questions worth asking
Ideas the web ties closely to this story that the explainer doesn't mention. These are prompts for your own research: Brind hasn't answered them.
-
About Centrefeed
Since the new line is high-speed, does the technology allow for the production of centrefeed tissue, and how might that affect GrandBay's market positioning?
-
About Facial Tissue
Given the high capacity of the new line, is the production focused on toilet tissue, or does it also include facial tissue?
Explore connected ideas
Each opens in Related concepts: what the web connects to it, with Brind's news on it.
The ideas come from how millions of web pages place them near each other. The questions are Brind's AI reasoning, written only from this explainer and Brind's own reporting.
Reporting
- pulpapernews.comOct 6
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. It is not investment advice; do your own research.